Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH HYDANTOIN INHIBITOR
 
Authors :  P. Orth
Date :  10 Dec 09  (Deposition) - 02 Mar 10  (Release) - 05 May 10  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.92
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Keywords :  Metal-Binding, Metalloprotease, Notch Signaling Pathway, Protease, Hydrolase-Hydrolase Inhibitor Complex (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  W. Yu, Z. Guo, P. Orth, V. Madison, L. Chen, C. Dai, R. J. Feltz, V. M. Girijavallabhan, S. H. Kim, J. A. Kozlowski, B. J. Lavey, D. Li, D. Lundell, X. Niu, J. J. Piwinski, J. Popovici-Muller, R. Rizvi, K. E. Rosner, B. B. Shankar, N. Y. Shih, M. A. Siddiqui, J. Sun, L. Tong, S. Umland, M. K. Wong, D. Y. Yang, G. Zhou
Discovery And Sar Of Hydantoin Tace Inhibitors.
Bioorg. Med. Chem. Lett. V. 20 1877 2010
PubMed-ID: 20172725  |  Reference-DOI: 10.1016/J.BMCL.2010.01.148

(-) Compounds

Molecule 1 - DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 17
    ChainsA, B
    EC Number3.4.24.86
    EngineeredYES
    Expression SystemTRICHOPLUSIA NI
    Expression System Taxid7111
    FragmentRESIDUES 215-476
    GeneADAM17, CSVP, TACE
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymADAM 17, TNF-ALPHA-CONVERTING ENZYME, TNF-ALPHA CONVERTASE, SNAKE VENOM-LIKE PROTEASE

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)A 
Biological Unit 2 (1x) B

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (4, 6)

Asymmetric Unit (4, 6)
No.NameCountTypeFull Name
1INN1Ligand/Ion3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYLPENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE
2IPA2Ligand/IonISOPROPYL ALCOHOL
3Z941Ligand/IonN-{4-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4-YL]PHENYL}ACETAMIDE
4ZN2Ligand/IonZINC ION
Biological Unit 1 (2, 2)
No.NameCountTypeFull Name
1INN1Ligand/Ion3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYLPENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE
2IPA1Ligand/IonISOPROPYL ALCOHOL
3Z94-1Ligand/IonN-{4-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4-YL]PHENYL}ACETAMIDE
4ZN-1Ligand/IonZINC ION
Biological Unit 2 (2, 2)
No.NameCountTypeFull Name
1INN-1Ligand/Ion3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYLPENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINE
2IPA1Ligand/IonISOPROPYL ALCOHOL
3Z941Ligand/IonN-{4-[(4S)-2,5-DIOXOIMIDAZOLIDIN-4-YL]PHENYL}ACETAMIDE
4ZN-1Ligand/IonZINC ION

(-) Sites  (6, 6)

Asymmetric Unit (6, 6)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREHIS A:405 , HIS A:409 , HIS A:415 , INN A:485 , HOH A:492BINDING SITE FOR RESIDUE ZN A 1
2AC2SOFTWAREZN A:1 , HOH A:167 , GLU A:327 , SER A:330 , LYS A:331 , MET A:345 , GLY A:346 , THR A:347 , LEU A:348 , GLY A:349 , ASN A:389 , TYR A:390 , VAL A:402 , HIS A:405 , GLU A:406 , HIS A:409 , HIS A:415 , PRO A:437 , ILE A:438 , ALA A:439 , HOH A:490 , HOH A:491 , HOH A:492 , HOH A:493BINDING SITE FOR RESIDUE INN A 485
3AC3SOFTWARESER A:287 , GLN A:289 , ASN A:299BINDING SITE FOR RESIDUE IPA A 7
4AC4SOFTWAREHIS B:405 , HIS B:409 , HIS B:415 , Z94 B:485BINDING SITE FOR RESIDUE ZN B 2
5AC5SOFTWAREZN B:2 , IPA B:8 , THR B:347 , LEU B:348 , GLY B:349 , LEU B:350 , LEU B:401 , VAL B:402 , HIS B:405 , GLU B:406 , HIS B:409 , HIS B:415 , PRO B:437 , ALA B:439 , HOH B:507 , HOH B:529 , HOH B:546 , HOH B:556BINDING SITE FOR RESIDUE Z94 B 485
6AC6SOFTWAREGLY B:346 , ILE B:438 , ALA B:439 , Z94 B:485BINDING SITE FOR RESIDUE IPA B 8

(-) SS Bonds  (6, 6)

Asymmetric Unit
No.Residues
1A:225 -A:333
2A:365 -A:469
3A:423 -A:453
4B:225 -B:333
5B:365 -B:469
6B:423 -B:453

(-) Cis Peptide Bonds  (3, 3)

Asymmetric Unit
No.Residues
1Tyr A:304 -Pro A:305
2Tyr B:304 -Pro B:305
3Ser B:355 -Pro B:356

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (0, 0)

(no "SAP(SNP)/Variant" information available for 3L0T)

(-) PROSITE Motifs  (2, 4)

Asymmetric Unit (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ADAM_MEPROPS50215 ADAM type metalloprotease domain profile.ADA17_HUMAN223-474
 
  2A:223-474
B:223-473
2ZINC_PROTEASEPS00142 Neutral zinc metallopeptidases, zinc-binding region signature.ADA17_HUMAN402-411
 
  2A:402-411
B:402-411
Biological Unit 1 (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ADAM_MEPROPS50215 ADAM type metalloprotease domain profile.ADA17_HUMAN223-474
 
  1A:223-474
-
2ZINC_PROTEASEPS00142 Neutral zinc metallopeptidases, zinc-binding region signature.ADA17_HUMAN402-411
 
  1A:402-411
-
Biological Unit 2 (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ADAM_MEPROPS50215 ADAM type metalloprotease domain profile.ADA17_HUMAN223-474
 
  1-
B:223-473
2ZINC_PROTEASEPS00142 Neutral zinc metallopeptidases, zinc-binding region signature.ADA17_HUMAN402-411
 
  1-
B:402-411

(-) Exons   (7, 14)

Asymmetric Unit (7, 14)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1bENST000003108231bENSE00001490067chr2:9695917-9695638280ADA17_HUMAN1-33330--
1.2ENST000003108232ENSE00001001245chr2:9683414-9683282133ADA17_HUMAN33-77450--
1.3ENST000003108233ENSE00001001246chr2:9676957-9676827131ADA17_HUMAN77-121450--
1.4ENST000003108234ENSE00001001240chr2:9676051-967596389ADA17_HUMAN121-150300--
1.5aENST000003108235aENSE00001070593chr2:9668083-9667915169ADA17_HUMAN151-207570--
1.6ENST000003108236ENSE00001070592chr2:9666373-9666240134ADA17_HUMAN207-251452A:218-251
B:220-251
34
32
1.7ENST000003108237ENSE00001070603chr2:9663467-966337890ADA17_HUMAN252-281302A:252-281
B:252-281
30
30
1.9ENST000003108239ENSE00001070599chr2:9661445-9661332114ADA17_HUMAN282-319382A:282-319
B:282-319
38
38
1.10ENST0000031082310ENSE00001070595chr2:9658376-9658232145ADA17_HUMAN320-368492A:320-368 (gaps)
B:320-368
49
49
1.11ENST0000031082311ENSE00001070597chr2:9658118-965803089ADA17_HUMAN368-397302A:368-397
B:368-397
30
30
1.12ENST0000031082312ENSE00001001237chr2:9650260-9650108153ADA17_HUMAN398-448512A:398-448
B:398-448
51
51
1.13ENST0000031082313ENSE00001001234chr2:9645494-9645295200ADA17_HUMAN449-515672A:449-474
B:449-473
26
25
1.14ENST0000031082314ENSE00001001242chr2:9642405-9642302104ADA17_HUMAN515-550360--
1.15ENST0000031082315ENSE00001001233chr2:9637377-9637243135ADA17_HUMAN550-595460--
1.16ENST0000031082316ENSE00001001250chr2:9634896-9634766131ADA17_HUMAN595-638440--
1.17ENST0000031082317ENSE00001001241chr2:9633954-963387679ADA17_HUMAN639-665270--
1.18ENST0000031082318ENSE00001490117chr2:9633115-963302789ADA17_HUMAN665-694300--
1.19ENST0000031082319ENSE00001001249chr2:9631280-963123051ADA17_HUMAN695-711170--
1.20ENST0000031082320ENSE00001367317chr2:9630647-96286152033ADA17_HUMAN712-8241130--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:254
 aligned with ADA17_HUMAN | P78536 from UniProtKB/Swiss-Prot  Length:824

    Alignment length:257
                                   227       237       247       257       267       277       287       297       307       317       327       337       347       357       367       377       387       397       407       417       427       437       447       457       467       
          ADA17_HUMAN   218 PDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTSWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSNCSKQSIYKTIESKAQECFQERS 474
               SCOP domains d3l0ta_ A: TNF-alpha converting enzyme, TACE, catalytic domain                                                                                                                                                                                                    SCOP domains
               CATH domains 3l0tA00 A:218-474 Collagenase (Catalytic Domain)                                                                                                                                                                                                                  CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ......eeeeeeeehhhhhhhh...hhhhhhhhhhhhhhhhhhhhhh...........eeeeeeeee............................hhhhhhhhhhhhhhhhhh...eeeeee...hhhhh.eee.....---........eeee....eeee..eeeee.ee..ee.hhhhhhhhhhhhhhhhh..............hhhhh....................hhhhhhhhhhhhhhhhhhhh.... Sec.struct. author
                 SAPs(SNPs) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) -----ADAM_MEPRO  PDB: A:223-474 UniProt: 223-474                                                                                                                                                                                                                  PROSITE (1)
                PROSITE (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ZINC_PROTE--------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.6  PDB: A:218-251          Exon 1.7  PDB: A:252-281      Exon 1.9  PDB: A:282-319              Exon 1.10  PDB: A:320-368 (gaps) UniProt: 320-368-----------------------------Exon 1.12  PDB: A:398-448 UniProt: 398-448         Exon 1.13  PDB: A:449-474  Transcript 1 (1)
           Transcript 1 (2) ------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.11  PDB: A:368-397     ----------------------------------------------------------------------------- Transcript 1 (2)
                 3l0t A 218 PDPMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTAWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYGGSP---SHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSQCSKQSIYKTIESKAQECFQERS 474
                                   227       237       247       257       267       277       287       297       307       317       327       337       347        |-  |    367       377       387       397       407       417       427       437       447       457       467       
                                                                                                                                                                    356 360                                                                                                                  

Chain B from PDB  Type:PROTEIN  Length:254
 aligned with ADA17_HUMAN | P78536 from UniProtKB/Swiss-Prot  Length:824

    Alignment length:254
                                   229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469    
          ADA17_HUMAN   220 PMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTSWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYVGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSNCSKQSIYKTIESKAQECFQER 473
               SCOP domains d3l0tb_ B: TNF-alpha converting enzyme, TACE, catalytic domain                                                                                                                                                                                                 SCOP domains
               CATH domains 3l0tB00 B:220-473 Collagenase (Catalytic Domain)                                                                                                                                                                                                               CATH domains
           Pfam domains (1) -Peptidase_M84-3l0tB01 B:221-451                                                                                                                                                                                                        ---------------------- Pfam domains (1)
           Pfam domains (2) -Peptidase_M84-3l0tB02 B:221-451                                                                                                                                                                                                        ---------------------- Pfam domains (2)
         Sec.struct. author ....eeeeeeeehhhhhhhh...hhhhhhhhhhhhhhhhhhhhhh...........eeeeeeeee............................hhhhhhhhhhhhhhhhhh...eeeeee...hhhhh.eee................eeee....eeee..eeeee.ee..ee.hhhhhhhhhhhhhhhhh..............hhhhh.............hhhhhh.hhhhhhhhhhhhhhhhhhhh... Sec.struct. author
                 SAPs(SNPs) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs)
                PROSITE (1) ---ADAM_MEPRO  PDB: B:223-473 UniProt: 223-474                                                                                                                                                                                                                 PROSITE (1)
                PROSITE (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ZINC_PROTE-------------------------------------------------------------- PROSITE (2)
           Transcript 1 (1) Exon 1.6  PDB: B:220-251        Exon 1.7  PDB: B:252-281      Exon 1.9  PDB: B:282-319              Exon 1.10  PDB: B:320-368 UniProt: 320-368       -----------------------------Exon 1.12  PDB: B:398-448 UniProt: 398-448         Exon 1.13  PDB: B:449-473 Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.11  PDB: B:368-397     ---------------------------------------------------------------------------- Transcript 1 (2)
                 3l0t B 220 PMKNTCKLLVVADHRFYRYMGRGEESTTTNYLIELIDRVDDIYRNTAWDNAGFKGYGIQIEQIRILKSPQEVKPGEKHYNMAKSYPNEEKDAWDVKMLLEQFSFDIAEEASKVCLAHLFTYQDFDMGTLGLAYGGSPRANSHGGVCPKAYYSPVGKKNIYLNSGLTSTKNYGKTILTKEADLVTTHELGHNFGAEHDPDGLAECAPNEDQGGKYVMYPIAVSGDHENNKMFSQCSKQSIYKTIESKAQECFQER 473
                                   229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429       439       449       459       469    

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (1, 2)

Asymmetric Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (1, 2)

Asymmetric Unit

(-) Gene Ontology  (60, 60)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (ADA17_HUMAN | P78536)
molecular function
    GO:0005112    Notch binding    Interacting selectively and non-covalently with the Notch (N) protein, a surface receptor.
    GO:0030165    PDZ domain binding    Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.
    GO:0017124    SH3 domain binding    Interacting selectively and non-covalently with a SH3 domain (Src homology 3) of a protein, small protein modules containing approximately 50 amino acid residues found in a great variety of intracellular or membrane-associated proteins.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0005178    integrin binding    Interacting selectively and non-covalently with an integrin.
    GO:0005138    interleukin-6 receptor binding    Interacting selectively and non-covalently with the interleukin-6 receptor.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0004222    metalloendopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0008237    metallopeptidase activity    Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0030183    B cell differentiation    The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
    GO:0007220    Notch receptor processing    The series of successive proteolytic cleavages of the Notch protein, which result in an active form of the receptor.
    GO:0007219    Notch signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to the receptor Notch on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0051088    PMA-inducible membrane protein ectodomain proteolysis    The proteolytic cleavage of transmembrane proteins and release of their ectodomain that occurs after induction by phorbol-12-myristate-13-acetate (PMA), a protein kinase C agonist.
    GO:0033077    T cell differentiation in thymus    The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus.
    GO:0007155    cell adhesion    The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules.
    GO:0033627    cell adhesion mediated by integrin    The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via an integrin, a heterodimeric adhesion receptor formed by the non-covalent association of particular alpha and beta subunits.
    GO:0048870    cell motility    Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another.
    GO:0050830    defense response to Gram-positive bacterium    Reactions triggered in response to the presence of a Gram-positive bacterium that act to protect the cell or organism.
    GO:0007173    epidermal growth factor receptor signaling pathway    A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0035625    epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway    The process in which an epidermal growth factor-activated receptor is activated via signaling events from a G-protein coupled receptor. This is an example of cross-talk between the EGF and GPCR signaling pathways.
    GO:0002467    germinal center formation    The process in which germinal centers form. A germinal center is a specialized microenvironment formed when activated B cells enter lymphoid follicles. Germinal centers are the foci for B cell proliferation and somatic hypermutation.
    GO:0006509    membrane protein ectodomain proteolysis    The proteolytic cleavage of transmembrane proteins and release of their ectodomain (extracellular domain).
    GO:0031293    membrane protein intracellular domain proteolysis    The proteolytic cleavage of a transmembrane protein leading to the release of an intracellular domain.
    GO:0030512    negative regulation of transforming growth factor beta receptor signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of any TGF-beta receptor signaling pathway.
    GO:0002446    neutrophil mediated immunity    Any process involved in the carrying out of an immune response by a neutrophil.
    GO:0010820    positive regulation of T cell chemotaxis    Any process that increases the rate, frequency or extent of T cell chemotaxis. T cell chemotaxis is the directed movement of a T cell in response to an external stimulus.
    GO:0030307    positive regulation of cell growth    Any process that activates or increases the frequency, rate, extent or direction of cell growth.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0051272    positive regulation of cellular component movement    Any process that activates or increases the frequency, rate or extent of the movement of a cellular component.
    GO:0032722    positive regulation of chemokine production    Any process that activates or increases the frequency, rate, or extent of chemokine production.
    GO:0031659    positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle    Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.
    GO:0045741    positive regulation of epidermal growth factor-activated receptor activity    Any process that activates or increases the frequency, rate or extent of EGF-activated receptor activity.
    GO:0002690    positive regulation of leukocyte chemotaxis    Any process that activates or increases the frequency, rate, or extent of leukocyte chemotaxis.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:0030511    positive regulation of transforming growth factor beta receptor signaling pathway    Any process that activates or increases the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0033025    regulation of mast cell apoptotic process    Any process that modulates the frequency, rate, or extent of mast cell apoptotic process.
    GO:0042493    response to drug    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
    GO:0055099    response to high density lipoprotein particle    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a high density lipoprotein particle stimulus.
    GO:0001666    response to hypoxia    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
    GO:0032496    response to lipopolysaccharide    Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
    GO:0048536    spleen development    The process whose specific outcome is the progression of the spleen over time, from its formation to the mature structure. The spleen is a large vascular lymphatic organ composed of white and red pulp, involved both in hemopoietic and immune system functions.
    GO:0033209    tumor necrosis factor-mediated signaling pathway    A series of molecular signals initiated by the binding of a tumor necrosis factor to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
    GO:0035313    wound healing, spreading of epidermal cells    The migration of an epidermal cell along or through a wound gap that contributes to the reestablishment of a continuous epidermis.
cellular component
    GO:0015629    actin cytoskeleton    The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes.
    GO:0016324    apical plasma membrane    The region of the plasma membrane located at the apical end of the cell.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005911    cell-cell junction    A cell junction that forms a connection between two or more cells in a multicellular organism; excludes direct cytoplasmic junctions such as ring canals.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005887    integral component of plasma membrane    The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0032587    ruffle membrane    The portion of the plasma membrane surrounding a ruffle.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    INN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    IPA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    Z94  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ZN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Ser B:355 - Pro B:356   [ RasMol ]  
    Tyr A:304 - Pro A:305   [ RasMol ]  
    Tyr B:304 - Pro B:305   [ RasMol ]  
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  3l0t
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ADA17_HUMAN | P78536
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.24.86
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ADA17_HUMAN | P78536
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ADA17_HUMAN | P785361bkc 1zxc 2a8h 2ddf 2fv5 2fv9 2i47 2m2f 2oi0 3b92 3cki 3e8r 3edz 3ewj 3g42 3kmc 3kme 3l0v 3le9 3lea 3lgp 3o64

(-) Related Entries Specified in the PDB File

1bkc CATALYTIC DOMAIN OF TNF-ALPHA CONVERTING ENZYME (TACE)
3kmc CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH TARTRATE -BASED INHIBITOR
3kme CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH PHENYL- PYRROLIDINYL-TARTRATE INHIBITOR
3l0v CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF TACE WITH THE FIRST HYDANTOIN INHIBITOR OCCUPYING THE S1 POCKET
3le9 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH INDAZOLINONE-PHENYL-HYDANTOIN INHIBITOR
3lea CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF TACE WITH ISOINDOLINONE-BIPHENYL-HYDANTOIN INHIBITOR